Under the Decree of the Government of the Russian Federation No. 1556 dated December 14, 2018 (hereinafter — Decree No. 1556), monitoring system of the medical drugs circulation should become effective from the January 2020 with the exception of medical drugs for healing high-cost ICD diseases, which have already been monitored from October1, 2019.

Ritz Carlton Moscow, December 5th 2019. The results of the annual Pravo.ru-300 law firms’ ranking were announced at an awarding ceremony at the Ritz Carlton Moscow.

In September the draft law was amended with a new provision on the creation of Register of pharmacologically active substances. Under this provision, Rospatent will keep the publicly available Register of pharmacologically active substances protected by patent.

The new review of the most notable patents disputes in Life Sciences in EAEU, CIS and Eastern Europe.

• pdf, 766.11 kb

Partner of the Lidings’ Intellectual Property practice Boris Malakhov will take part in a C5’s Pharmaceutical Patent Term Extensions conference scheduled to take place on 25-26 of June 2019 in Munich.

Lidings’ Intellectual Property practice Associate Roman Vlasov will run a webinar on Using Personal Data of Clients: How to Handle and Avoid Claims from Roskomnadzor organized by Caselook.

Lidings’ Associate Nadezhda Fedotova will speak at a conference entitled “Labeling in Pharmaceutical Industry”. The event will take place in Moscow on May 24th at Ararat Park Hyatt Hotel.

Lidings’ Managing Partner, Head of the pharmaceuticals and healthcare industry practice of the firm Andrey Zelenin will speak at the 25th Russian Pharmaceutical Forum annually organized in Saint Petersburg by the Adam Smith Institute with Lidings’ support. The jubilee event will take place on 14-15 of May 2019, traditionally hosted by one of the city’s central locations — Corinthia Hotel.

Under the Federal Law “On drugs circulation” (Law), information on state registration of drugs in Russia shall be publicly available.